Form 4: U.S. Physical Therapy CEO Christopher Reading Sells 2,900 Shares
SEC Form 4
Christopher Reading, Chairman and CEO of U.S. Physical Therapy, sold 2,900 shares of common stock at an average price of $100.26 on May 30, 2024.
Summary
- On May 30, 2024, Christopher Reading, the Chairman and CEO of U.S. Physical Therapy Inc., sold 2,900 shares of the company's common stock.
- The shares were sold at a weighted average price of $100.26, with individual transaction prices ranging from $100.00 to $100.90.
- Following the transaction, Reading directly owns 95,838 shares, which includes 32,913 restricted shares granted under the company's stock incentive plan.
- These restricted shares vest in installments between July 1, 2024, and January 1, 2028, contingent upon Reading's continued employment as an officer of the company.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a routine stock sale by the CEO. The sentiment is neutral as it simply reports a transaction without expressing any positive or negative outlook.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Investors often monitor these filings to gauge management's sentiment and confidence in the company's prospects.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders, potentially causing a slight decrease in stock price due to increased supply.
- The vesting schedule of restricted stock incentivizes the CEO to remain with the company, aligning his interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/30/2024 | Date of stock sale transaction |
| 05/31/2024 | Date of Form 4 filing |
| 07/01/2024 | First vesting date of restricted stock (3,587 shares) |
| 10/01/2024 | Second vesting date of restricted stock (3,587 shares) |
| 01/01/2025 | Third vesting date of restricted stock (3,588 shares) |
| 04/01/2025 | Fourth vesting date of restricted stock (2,887 shares) |
| 07/01/2025 | Fifth vesting date of restricted stock (2,887 shares) |
| 10/01/2025 | Sixth vesting date of restricted stock (2,887 shares) |
| 01/01/2026 | Seventh vesting date of restricted stock (2,888 shares) |
| 04/01/2026 | Eighth vesting date of restricted stock (1,637 shares) |
| 07/01/2026 | Ninth vesting date of restricted stock (1,637 shares) |
| 10/01/2026 | Tenth vesting date of restricted stock (1,637 shares) |
| 01/01/2027 | Eleventh vesting date of restricted stock (1,638 shares) |
| 04/01/2027 | Twelfth vesting date of restricted stock (1,012 shares) |
| 07/01/2027 | Thirteenth vesting date of restricted stock (1,012 shares) |
| 10/01/2027 | Fourteenth vesting date of restricted stock (1,012 shares) |
| 01/01/2028 | Fifteenth vesting date of restricted stock (1,017 shares) |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.